Science ❯Biology ❯Immunology ❯Antibodies

Broadly Neutralizing Antibodies

Single Birth Injection Protects Primates From HIV, Paves Way for Newborn Safety Trials

Phase 1/2 safety trials in human newborns are being planned after primate studies showed durable HIV protection, with researchers addressing immunogenicity, strain diversity, production scalability.

5 ARTICLES

2mo ago

Early HIV Vaccine Trials Achieve Precise Immune Activation in Humans

3 ARTICLES

last yr.

Experimental HIV Vaccine Shows Promise in Early Human Trials

4 ARTICLES

last yr.

Promising HIV Vaccine Induces Broadly Neutralizing Antibodies in Early Trials